TOT BIOPHARM International Company Limited 1875.HK Stock
TOT BIOPHARM International Company Limited Price Chart
TOT BIOPHARM International Company Limited 1875.HK Financial and Trading Overview
Contents
- TOT BIOPHARM International Company Limited Price Chart
- TOT BIOPHARM International Company Limited 1875.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of TOT BIOPHARM International Company Limited
- Q&A For TOT BIOPHARM International Company Limited Stock
| TOT BIOPHARM International Company Limited stock price | 1.67 HKD |
| Previous Close | 2.23 HKD |
| Open | 2.23 HKD |
| Bid | 2.3 HKD x N/A |
| Ask | 2.38 HKD x N/A |
| Day's Range | 2.2 - 2.23 HKD |
| 52 Week Range | 1.66 - 3.23 HKD |
| Volume | 54K HKD |
| Avg. Volume | 86.44K HKD |
| Market Cap | 1.78B HKD |
| Beta (5Y Monthly) | 0.214149 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
1875.HK Valuation Measures
| Enterprise Value | 1.55B HKD |
| Trailing P/E | N/A |
| Forward P/E | -4.893617 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.019676 |
| Price/Book (mrq) | 2.4891775 |
| Enterprise Value/Revenue | 3.513 |
| Enterprise Value/EBITDA | -350.762 |
Trading Information
TOT BIOPHARM International Company Limited Stock Price History
| Beta (5Y Monthly) | 0.214149 |
| 52-Week Change | -28.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.23 HKD |
| 52 Week Low | 1.66 HKD |
| 50-Day Moving Average | 2.36 HKD |
| 200-Day Moving Average | 2.39 HKD |
1875.HK Share Statistics
| Avg. Volume (3 month) | 86.44K HKD |
| Avg. Daily Volume (10-Days) | 39.76K HKD |
| Shares Outstanding | 772.79M |
| Float | 228.81M |
| Short Ratio | N/A |
| % Held by Insiders | 41.98% |
| % Held by Institutions | 28.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -11.28% |
| Operating Margin (ttm) | -8.80% |
| Gross Margin | 83.81% |
| EBITDA Margin | -1.00099% |
Management Effectiveness
| Return on Assets (ttm) | -2.46% |
| Return on Equity (ttm) | -9.52% |
Income Statement
| Revenue (ttm) | 442.18M HKD |
| Revenue Per Share (ttm) | 0.69 HKD |
| Quarterly Revenue Growth (yoy) | 389.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -4428000 HKD |
| Net Income Avi to Common (ttm) | -49916000 HKD |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 461.23M HKD |
| Total Cash Per Share (mrq) | 0.6 HKD |
| Total Debt (mrq) | 289.53M HKD |
| Total Debt/Equity (mrq) | 40.47 HKD |
| Current Ratio (mrq) | 2.458 |
| Book Value Per Share (mrq) | 0.924 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 59.93M HKD |
| Levered Free Cash Flow (ttm) | -194277120 HKD |
Profile of TOT BIOPHARM International Company Limited
| Country | Hong Kong |
| State | N/A |
| City | Suzhou |
| Address | No. 120 Changyang Street |
| ZIP | 215024 |
| Phone | 86 512 6296 5186 |
| Website | https://www.totbiopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 431 |
TOT BIOPHARM International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in China. The company develops TAB008 for the treatment of non-squamous non-small-cell lung cancer, metastatic colorectal cancer, glioblastoma multiforme, ovarian cancer, cervical cancer, fallopian tube cancer, or primary peritoneal cancer, and hepatocellular carcinoma. It also offers TOZ309 for the treatment of glioblastoma multiforme or anaplastic astrocytoma. In addition, the company develops TAA013 for HER2+ breast cancer; TAE020 which is under preclinical trial for acute myeloid leukemia; and TAB014 for wet age-related macular degeneration. Further it develops TAC020 for the treatment various solid tumors. TOT BIOPHARM International Company Limited was incorporated in 2009 and is headquartered in Suzhou, China.
Q&A For TOT BIOPHARM International Company Limited Stock
What is a current 1875.HK stock price?
TOT BIOPHARM International Company Limited 1875.HK stock price today per share is 1.67 HKD.
How to purchase TOT BIOPHARM International Company Limited stock?
You can buy 1875.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TOT BIOPHARM International Company Limited?
The stock symbol or ticker of TOT BIOPHARM International Company Limited is 1875.HK.
Which industry does the TOT BIOPHARM International Company Limited company belong to?
The TOT BIOPHARM International Company Limited industry is Biotechnology.
How many shares does TOT BIOPHARM International Company Limited have in circulation?
The max supply of TOT BIOPHARM International Company Limited shares is 772.79M.
What is TOT BIOPHARM International Company Limited Price to Earnings Ratio (PE Ratio)?
TOT BIOPHARM International Company Limited PE Ratio is now.
What was TOT BIOPHARM International Company Limited earnings per share over the trailing 12 months (TTM)?
TOT BIOPHARM International Company Limited EPS is -0.05 HKD over the trailing 12 months.
Which sector does the TOT BIOPHARM International Company Limited company belong to?
The TOT BIOPHARM International Company Limited sector is Healthcare.